Solvent front mutations are the most common type of resistance mutations occurring in approximately 40–50% of NSCLC driven by ALK, NTRK1, NTRK2, NTRK3 and ROS1 rearrangements24,25. Here, ALK is linked to non-small cell lung carcinoma.